Article ID Journal Published Year Pages File Type
8754990 Auris Nasus Larynx 2017 4 Pages PDF
Abstract
The involvement of S-1 chemotherapy in ATLL development suggests that a test for HTLV-1 antibody should be performed before treatment and that S-1 should not be administered in HTLV-1 positive patients with head and neck carcinoma.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Preview
Adult T-cell leukemia/lymphoma in patients with head and neck cancer after S-1 chemotherapy
Authors
, , ,